Cantargia Appoints Monic Stuart Chief Medical Officer
Cantargia appointed Monic Stuart, MD, PhD, MBA as chief medical officer, effective immediately. She will lead nadunolimab’s clinical development in hematologic cancers and solid tumors.
Cantargia appointed Monic Stuart, MD, PhD, MBA as chief medical officer, effective immediately. She will lead nadunolimab’s clinical development in hematologic cancers and solid tumors.